A detailed history of Greenleaf Trust transactions in Zoetis Inc. stock. As of the latest transaction made, Greenleaf Trust holds 8,493 shares of ZTS stock, worth $1.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,493
Previous 8,343 1.8%
Holding current value
$1.5 Million
Previous $1.45 Million 14.73%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$172.58 - $196.48 $25,887 - $29,472
150 Added 1.8%
8,493 $1.66 Million
Q2 2024

Jul 22, 2024

SELL
$145.54 - $178.83 $68,840 - $84,586
-473 Reduced 5.37%
8,343 $1.45 Million
Q1 2024

Apr 29, 2024

BUY
$165.67 - $199.94 $3,976 - $4,798
24 Added 0.27%
8,816 $1.49 Million
Q4 2023

Jan 31, 2024

BUY
$151.44 - $200.09 $7,874 - $10,404
52 Added 0.59%
8,792 $1.74 Million
Q3 2023

Nov 09, 2023

BUY
$167.14 - $192.77 $47,802 - $55,132
286 Added 3.38%
8,740 $1.52 Million
Q2 2023

Aug 09, 2023

SELL
$160.94 - $186.23 $126,820 - $146,749
-788 Reduced 8.53%
8,454 $1.46 Million
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $276,557 - $332,713
1,901 Added 25.9%
9,242 $1.54 Million
Q4 2022

Jan 25, 2023

BUY
$131.14 - $157.47 $48,652 - $58,421
371 Added 5.32%
7,341 $1.08 Million
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $63,468 - $78,131
-428 Reduced 5.79%
6,970 $1.03 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $28,854 - $37,016
-185 Reduced 2.44%
7,398 $1.27 Million
Q1 2022

Apr 27, 2022

BUY
$181.39 - $234.03 $8,343 - $10,765
46 Added 0.61%
7,583 $1.43 Million
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $140,037 - $178,602
723 Added 10.61%
7,537 $1.84 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $57,922 - $64,165
306 Added 4.7%
6,814 $1.32 Million
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $89,174 - $107,530
572 Added 9.64%
6,508 $1.21 Million
Q1 2021

Apr 30, 2021

BUY
$144.0 - $169.39 $148,032 - $174,132
1,028 Added 20.95%
5,936 $935,000
Q4 2020

Feb 08, 2021

BUY
$157.07 - $174.35 $39,581 - $43,936
252 Added 5.41%
4,908 $812,000
Q3 2020

Oct 30, 2020

BUY
$137.1 - $165.37 $47,573 - $57,383
347 Added 8.05%
4,656 $770,000
Q2 2020

Aug 12, 2020

SELL
$111.92 - $142.53 $54,616 - $69,554
-488 Reduced 10.17%
4,309 $591,000
Q1 2020

Apr 29, 2020

BUY
$92.66 - $144.94 $30,763 - $48,120
332 Added 7.44%
4,797 $565,000
Q4 2019

Feb 11, 2020

SELL
$116.25 - $133.25 $15,228 - $17,455
-131 Reduced 2.85%
4,465 $591,000
Q3 2019

Nov 08, 2019

BUY
$112.57 - $128.43 $88,367 - $100,817
785 Added 20.6%
4,596 $573,000
Q2 2019

Jul 24, 2019

BUY
$97.98 - $114.28 $30,863 - $35,998
315 Added 9.01%
3,811 $433,000
Q1 2019

May 08, 2019

BUY
$81.56 - $100.67 $22,102 - $27,281
271 Added 8.4%
3,496 $352,000
Q4 2018

Feb 07, 2019

SELL
$79.28 - $95.27 $34,645 - $41,632
-437 Reduced 11.93%
3,225 $276,000
Q3 2018

Oct 29, 2018

BUY
$83.5 - $93.23 $13,443 - $15,010
161 Added 4.6%
3,662 $335,000
Q2 2018

Aug 07, 2018

BUY
$79.9 - $89.2 $253,043 - $282,496
3,167 Added 948.2%
3,501 $298,000
Q1 2018

Apr 30, 2018

SELL
$71.51 - $84.69 $20,165 - $23,882
-282 Reduced 45.78%
334 $28,000
Q4 2017

Feb 08, 2018

SELL
$63.24 - $72.8 $7,525 - $8,663
-119 Reduced 16.19%
616 $44,000
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $43,901 - $48,069
735
735 $47,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.